Laparoscopic Sleeve Gastrectomy With Endoscopic Visualization

Exclusion Criteria

• •Subjects will be excluded from the study for any of the following:
• •Previous pelvic surgery other than transverse C-sections and/or tubal ligation;
• •Enlarged uterus;
• •Evidence of pelvic malignancy on a screening ultrasound;
• •Documented history of drug and/or alcohol abuse within 2 years of the Screening Visit;
• •Previous malabsorptive or restrictive procedures performed for the treatment of obesity;
• •Unable or unwilling to attend follow-up visits and examinations;
• •Planned or predicted concurrent surgical procedure;
• •Any medical condition which precludes compliance with the study;
• •Immunocompromised such as that resulting from chronic oral steroid use, chemotherapeutic agents, or immune deficiency disorders;
• •Conditions that, in the opinion of the investigator, may jeopardize the subject's well-being and/or the soundness of this clinical study;
• •History or presence of pre-existing autoimmune connective tissue disease, e.g., systemic lupus erythematosus or scleroderma;
• •Use of prescription or over the counter weight reduction medications or supplements, participation in weight-loss programs, or change in smoking habits within 8 weeks of the Screening Visit and for the duration of study participation;
• •Participation in another clinical trial within 8 weeks of the Screening Visit and for the duration of this trial (unless previously approved by the investigator and Sponsor); or
• •Any condition which precludes compliance with the study (investigator discretion).